Trends in Apolipoprotein and Troponin Levels Among Owerri Residents with Diabetes
DOI:
https://doi.org/10.59890/ijist.v3i3.535Keywords:
Troponins, Apolipoproteins, DiabetesAbstract
A cross-sectional study was carried out to determine the levels of apolipoproteins and troponins in individuals with diabetes who were attending the Specialist Hospital Owerri. The study participants included 100 individuals with diabetes and 100 individuals in the control group, all between the ages of 40 and 70. The blood samples were allowed to coagulate, centrifuged, and the serum was used to determine the levels of Troponins 1 and T and Apolipoproteins A-1 and B. The data was analyzed using the statistical program for social sciences, version 21, Windows 9, and the results were expressed as mean ± standard deviation and student t-test. In individuals with diabetes, the ratio of Apolipoproteins B/Apolipoproteins A-1, Troponin 1, Troponin T, and Apolipoprotein B was significantly greater. In relation to sex, male individuals with diabetes exhibited significantly greater Troponin T levels than female individuals with diabetes. Patients with obesity, myocardial infarction, coronary heart disease, artherosclerotic disease, dyslipidemia, vascular hypertrophy, and other complications related to hypertension may benefit from routine laboratory testing where apolipoproteins can be used to predict, manage, and assess the risk of the disease and ultimately improve treatment outcomes.
References
Geddes J, Deans KA, Cormack A, Motherwell D, Paterson K, O’Reilly DS, Fisher BM (2007). Cardiac troponin I concentrations in people presenting with diabetic ketoacidosis. Ann Clin Biochem.;44(Pt 4):391–393.
Han Y, Xie H, Liu Y, Gao P, Yang X, Shen Z (2019). Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis. Cardiovasc Diabetol. 18(1):1–16.
Maack C, Lehrke M, Backs J, (2018) Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the translational research committee of the Heart Failure Association-European Society of Cardiology. Eur Heart J.;39(48):4243–4254.
Vander Vorst, E.P. (2020): “High density lipoproteins and Apolipoprotein A1” Vertebrate and invertebrate respiratory proteins, lipoproteins and other body fluid proteins. Subcellular Biochemistry 94(2):399-420.
Zhu W, Lai Z, Xue M, Feng S, Feng P, Pan X, Ke X, Chen X, Li Z, Mao H, Yang X, Huang F, Chen W, Xu Y, Li S, Guo Q.(2025) Elevated concentrations of cardiac troponin T are associated with thoracic aortic calcification in non-dialysis chronic kidney disease patients of stage G3 to G5.Ren Fail.;47(1):244
Segre CAW, Hueb W, Garcia RMR, Rezende PC, Favarato D, Strunz CMC, (2015). Troponin in diabetic patients with and without chronic coronary artery disease. BMC Cardiovasc Disord. 15(1):72.
Xie H, Shen L, Yu P, Wang S, Sun T, Liu X, Wang M, Qian L, Hua J, Chen N, Chen X, Tang S.(2024)Associations of elevated cardiac biomarkers with hyperuricemia and mortality in US adults without prevalent cardiovascular disease.Front Endocrinol (Lausanne). 5;15:1432
.Agewall S, Giannitsis E, Jernberg T, Katus H (2011). Troponin elevation in coronary vs. non-coronary disease. Eur Heart J. 32(4):404–411
Wettersten N, Maisel A (2015). Role of cardiac troponin levels in acute heart failure. Card Fail Rev. 1(2):102–106.
Fure B, Bruun Wyller T, Thommessen B (2006). Electrocardiographic and troponin T changes in acute ischaemic stroke. J Intern Med.259(6):592–597.
Al-Mallah M, Zuberi O, Arida M, Kim HE(2008). Positive troponin in diabetic ketoacidosis without evident acute coronary syndrome predicts adverse cardiac events. Clin Cardiol. 31(2):67–71.
Savonitto S, Morici N, Nozza A, Cosentino F, Perrone Filardi P, Murena E, (2018). Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes. Diabetes Vasc Dis Res. 15(1):14–23
Eubanks A, Raza F, Alkhouli M, Glenn AN, Homko C, Kashem A, Bove A (2012). Clinical significance of troponin elevations in acute decompensated diabetes without clinical acute coronary syndrome. Cardiovasc Diabetol. 11(1):154–161.
Hernández C, Candell-Riera J, Ciudin A, Francisco G, Aguadé-Bruix S, Simó R (2011). Prevalence and risk factors accounting for true silent myocardial ischemia: a pilot case-control study comparing type 2 diabetic with non-diabetic control subjects. Cardiovasc Diabetol. 10(1):9–15.
Jensen JK, Atar D, Mickley H (2007). Mechanism of troponin elevations in patients with acute ischemic stroke. Am J Cardiol. 99(6):867–870.
James P, Ellis CJ, Whitlock RML, McNeil AR, Henley J, Anderson NE (2000). Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study. Br Med J. 320(7248):1502–1504
Ozougwu JC, Obimba KC, Belonwu CD, Unakalamba CB(2013). The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J Physiol Pathophysiol. 4(4):46–57.
Raffield LM, Hsu FC, Cox AJ, Carr JJ, Freedman BI, Bowden DW (2015). Predictors of all-cause and cardiovascular disease mortality in type 2 diabetes: Diabetes Heart Study. Diabetol Metab Syndr. 7(1):58.
Welsh P, Preiss D, Hayward C, (2020) The biomarkers for acute myocardial infarction and heart failure. Biomed Res Int. 17(2020):2754–2764.
Gottlieb A, Yanover C, Cahan A, Goldschmidt Y (2017). Estimating the effects of second-line therapy for type 2 diabetes mellitus: Retrospective Cohort Study. BMJ Open Diabetes Res Care. 1(5):1.
Chaudhury A, Duvoor C, Reddy Dendi VS, (2017) Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management. Front Endocrinol (Lausanne);8(6).
Ogurtsova K, daRocha Fernandes JD, Huang Y, (2017) IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 1(128):40–50.
Zimmermann M, Bunn C, Namadingo H, Gray CM, Lwanda J (2018). Experiences of type 2 diabetes in sub-Saharan Africa: a scoping review. Glob Health Res Policy.;3(1):25.
Zekewos A, Loha E, Egeno T, Wubshet K, Merga Z(2018). Prevalence of diabetes mellitus and associated factors in Southern Ethiopia: a Community Based Study. Ethiop J Health Sci.;28(4):451–460.
De Rosa S, Arcidiacono B, Chiefari E, Brunetti A, Indolfi C, Foti DP(2018).. Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links. Front Endocrinol (Lausanne). 9(2).
Tang O, Matsushita K, Coresh J, (2019). use of high sensitivity cardiac troponin T and I for risk classification in type 2 diabetes. Diabetes.;68(supplement):1. -25
